{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:12:32Z","timestamp":1788210752436,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Intensive and Critical Care Nursing"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.iccn.2025.104265","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:55:16Z","timestamp":1761461716000},"page":"104265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effect of ultrashort-acting \u03b2-blocker on the mortality of patients with sepsis or septic shock: A systematic review and trial sequential meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"92","author":[{"given":"Po-Yu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jheng-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Hsuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hsiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-2388","authenticated-orcid":false,"given":"Chih-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccn.2025.104265_b0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.iccn.2025.104265_b0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.iccn.2025.104265_b0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.iccn.2025.104265_b0020","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00134-015-4018-4","article-title":"Understanding stress cardiomyopathy","volume":"42","author":"Hollenberg","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00392-011-0375-3","article-title":"Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study","volume":"101","author":"Hoke","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.iccn.2025.104265_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcrc.2020.02.014","article-title":"Relationship between norepinephrine dose, tachycardia and outcome in septic shock: a multicentre evaluation","volume":"57","author":"Domizi","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.iccn.2025.104265_b0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40560-021-00552-w","article-title":"\u03b21-blocker in sepsis","volume":"9","author":"Hasegawa","year":"2021","journal-title":"J Intensive Care"},{"key":"10.1016\/j.iccn.2025.104265_b0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/SHK.0000000000001905","article-title":"Esmolol to treat the hemodynamic effects of septic shock: a randomized controlled trial","volume":"57","author":"Cocchi","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.iccn.2025.104265_b0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12871-023-01983-8","article-title":"Evaluating the effects of Esmolol on cardiac function in patients with Septic cardiomyopathy by Speck-tracking echocardiography-a randomized controlled trial","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.iccn.2025.104265_b0055","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.iccn.2025.104265_b0060","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.iccn.2025.104265_b0065","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2023.20134","article-title":"Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial","author":"Whitehouse","year":"2023","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.iccn.2025.104265_b0070","doi-asserted-by":"crossref","unstructured":"Wang Z, Wu Q, Nie X, et al. Combination therapy with milrinone and esmolol for heart protection in pat primary outcome primary outcome ients with severe sepsis: a prospective, randomized trial. Clin Drug Investig 2015;35:707-16.","DOI":"10.1007\/s40261-015-0325-3"},{"key":"10.1016\/j.iccn.2025.104265_b0075","first-page":"254","article-title":"Esmolol for septic shock: more than just heart rate control?","volume":"80","author":"Orbegozo Cortes","year":"2014","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.iccn.2025.104265_b0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajem.2017.11.013","article-title":"The influence of esmolol on septic shock and sepsis: a meta-analysis of randomized controlled studies","volume":"36","author":"Liu","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.iccn.2025.104265_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154916","article-title":"Prognosis of \u03b2-adrenergic blockade therapy on septic shock and sepsis: a systematic review and meta-analysis of randomized controlled studies","volume":"126","author":"Li","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.iccn.2025.104265_b0090","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.chest.2021.01.009","article-title":"Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials","volume":"159","author":"Hasegawa","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.iccn.2025.104265_b0095","article-title":"The efficacy and safety of esmolol for septic shock: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Huang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.iccn.2025.104265_b0100","article-title":"Benefits of esmolol in adults with sepsis and septic shock: an updated meta-analysis of randomized controlled trials","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.iccn.2025.104265_b0105","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.iccn.2025.104265_b0110","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.iccn.2025.104265_b0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13054-023-04561-z","article-title":"Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Wu","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.iccn.2025.104265_b0120","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.iccn.2025.104265_b0125","article-title":"Association between the \u03b2-blocker use and patients with sepsis: a cohort study","volume":"10","author":"Yang","year":"2023","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.iccn.2025.104265_b0130","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C (2017). User Manual for Trial Sequential Analysis (TSA) [pdf]. 2nd ed. Copenhagen: Copenhagen Trial Unit, pp. 1-119. Downloadable from ctu.dk\/tsa."},{"key":"10.1016\/j.iccn.2025.104265_b0135","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.CCM.0000261893.72811.0F","article-title":"Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock","volume":"35","author":"Varpula","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3892\/etm.2015.2863","article-title":"Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis","volume":"11","author":"Wang","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.iccn.2025.104265_b0145","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00134-016-4351-2","article-title":"Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study","volume":"42","author":"Morelli","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0022-4804(90)90142-O","article-title":"Effect of propranolol on nitrogen and energy metabolism in sepsis","volume":"48","author":"Dickerson","year":"1990","journal-title":"J Surg Res"},{"key":"10.1016\/j.iccn.2025.104265_b0155","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s13054-014-0610-1","article-title":"Effects of selective \u03b21-adrenoceptor blockade on cardiovascular and renal function and circulating cytokines in ovine hyperdynamic sepsis","volume":"18","author":"Calzavacca","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.iccn.2025.104265_b0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s001340050344","article-title":"Platelet function in septic multiple organ dysfunction syndrome","volume":"23","author":"Gawaz","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.735841","article-title":"Beta-adrenergic blockade in critical illness","volume":"12","author":"Bruning","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.iccn.2025.104265_b0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/cc8026","article-title":"Bench-to-bedside review: Beta-adrenergic modulation in sepsis","volume":"13","author":"de Montmollin","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.iccn.2025.104265_b0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress","volume":"24","author":"D\u00fcnser","year":"2009","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0180","doi-asserted-by":"crossref","first-page":"S608","DOI":"10.1097\/CCM.0b013e3181f204ca","article-title":"Beta-block the septic heart","volume":"38","author":"Rudiger","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0185","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1097\/CCM.0000000000005503","article-title":"The \u03b2 1 -adrenergic receptor contributes to sepsis-induced immunosuppression through modulation of regulatory T-cell inhibitory function","volume":"50","author":"Durand","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0190","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/j.jvca.2019.10.017","article-title":"Adrenergic downregulation in critical care: molecular mechanisms and therapeutic evidence","volume":"34","author":"Belletti","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.iccn.2025.104265_b0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13613-021-00869-7","article-title":"The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review","volume":"11","author":"Carrara","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.iccn.2025.104265_b0200","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1177\/08850666211052926","article-title":"Effect of premorbid beta-blockers on mortality in patients with sepsis: a systematic review and meta-analysis","volume":"37","author":"Hasegawa","year":"2022","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0205","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-019-2562-y","article-title":"The association between premorbid beta blocker exposure and mortality in sepsis-a systematic review","volume":"23","author":"Tan","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.iccn.2025.104265_b0210","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/CCM.0000000000005034","article-title":"Association between premorbid beta-blocker exposure and sepsis outcomes-the beta-blockers in european and australian\/american septic patients (BEAST) study","volume":"49","author":"Tan","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40560-021-00553-9","article-title":"Premorbid \u03b21-selective (but not non-selective) \u03b2-blocker exposure reduces intensive care unit mortality among septic patients","volume":"9","author":"Kuo","year":"2021","journal-title":"J Intensive Care"},{"key":"10.1016\/j.iccn.2025.104265_b0220","article-title":"Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies","volume":"10","author":"Hong","year":"2023","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.iccn.2025.104265_b0225","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0230","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jama.2016.20328","article-title":"Prognostic accuracy of the SOFA score, SIRS Criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit","volume":"317","author":"Raith","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.iccn.2025.104265_b0235","article-title":"Effects of esmolol assisted extracorporeal membrane oxygenation on treatment and prognosis of refractory septic shock with respiratory failure in adults","volume":"31","author":"Chen","year":"2023","journal-title":"China Med Eng"},{"key":"10.1016\/j.iccn.2025.104265_b0240","article-title":"Observation of the effects of esmolol on cardiac dysfunction due to septic shock","volume":"24","author":"Chu","year":"2017","journal-title":"Chinese J Rural Med Pharmacy"},{"key":"10.1016\/j.iccn.2025.104265_b0245","article-title":"The impact of esmolol on hemodynamics and prognosis in patients with septic shock","volume":"55","author":"Dou","year":"2015","journal-title":"Shandong Med J"},{"key":"10.1016\/j.iccn.2025.104265_b0250","article-title":"Protective effect of esmolol on myocardial injury in septic patients","volume":"35","author":"Gao","year":"2015","journal-title":"Chinese J Critical Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0255","article-title":"The value of maximal rate of left ventricular pressure in evaluating cardiac function in patients with sepsisinduced cardiomyopathy","volume":"35","author":"Wang","year":"2023","journal-title":"Chinese Critical Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0260","article-title":"Effect of esmolol in septic shock patients with tachycardia: a randomized clinical trial","volume":"99","author":"Liu","year":"2019","journal-title":"Nat Med J China"},{"key":"10.1016\/j.iccn.2025.104265_b0265","article-title":"Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock controlling heart rate","volume":"27","author":"Liu","year":"2015","journal-title":"Chinese Crit Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0270","article-title":"Effects of esmolol-assisted early goal-directed therapy on myocardial function and prognosis of patients with severe sepsis","volume":"19","author":"Liu","year":"2022","journal-title":"Drug Evaluation"},{"key":"10.1016\/j.iccn.2025.104265_b0275","article-title":"Efficacy observation of esmolol combined with norepinephrine in the treatment of patients with septic shock","volume":"45","author":"Liu","year":"2021","journal-title":"Heilongjiang Med J"},{"key":"10.1016\/j.iccn.2025.104265_b0280","article-title":"Effect of esmolol-assisted fluid resuscitation in the treatment of septic shock and the influence on nod-like receptor protein 2, \u03b1-enolase 1, and procalcitonin levels. Hainan Medical","volume":"34","author":"Tian","year":"2023","journal-title":"Journal"},{"key":"10.1016\/j.iccn.2025.104265_b0285","article-title":"Effects of esmolol on heart rate and prognosis in patients with septic shock","volume":"4","author":"Wang","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.iccn.2025.104265_b0290","article-title":"Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock","volume":"29","author":"Wang","year":"2017","journal-title":"Chinese Critical Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0295","article-title":"Curative effect of esmolol combined with early goal-directed therapy on sepsis cardiomyopathy","volume":"57","author":"Xiao","year":"2022","journal-title":"Nat Med J China"},{"key":"10.1016\/j.iccn.2025.104265_b0300","article-title":"Effects of the \u03b2 - blockers on cardiac protection and hemodynamics in patients with septic shock:a prospective study","volume":"26","author":"Yang","year":"2014","journal-title":"Chinese Critical Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0305","article-title":"Clinical study on the cardioprotection of esmolol in patients with septic shock","volume":"12","author":"Yang","year":"2019","journal-title":"Chinese Crit Care Med"},{"key":"10.1016\/j.iccn.2025.104265_b0310","article-title":"The effect of esmolol on the metabolism of patients with septic shock. Guide of","volume":"16","author":"Wang","year":"2018","journal-title":"Chin Med"},{"key":"10.1016\/j.iccn.2025.104265_b0315","article-title":"Effect of adrenergic \u03b21-antagonists on hemodynamic and inflammatory responses in patients with septic shock","volume":"36","author":"Zeng","year":"2016","journal-title":"Chinese Journal of Critical Care Medicine"},{"key":"10.1016\/j.iccn.2025.104265_b0320","article-title":"Influence of esmolol on cytokines by peripheral blood lymphocyte and ventricular function in patients with sepsis","volume":"21","author":"Zeng","year":"2017","journal-title":"Anhui Med Pharm J"},{"key":"10.1016\/j.iccn.2025.104265_b0325","article-title":"Effects of esmolol on cardiac function, inflammatory markers, and prognosis in elderly patients with septic shock","volume":"17","author":"Zhou","year":"2019","journal-title":"Clin Med J"},{"key":"10.1016\/j.iccn.2025.104265_b0330","article-title":"The effect of heart rate control of \u03b21-receptor antagonists on hemodynamics and prognosis in patients with septic shock","volume":"18","author":"Liu","year":"2017","journal-title":"J Clin Emergency Call"},{"key":"10.1016\/j.iccn.2025.104265_b0335","article-title":"Functional changes of heart and microcirculation in patients with septic shock and analysis of the hemodynamic effects of beta blockers","volume":"26","author":"Sun","year":"2016","journal-title":"Chinese J Nosocomiol"},{"key":"10.1016\/j.iccn.2025.104265_b0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.chest.2024.08.020","article-title":"Mortality in patients with sepsis treated with esmolol or landiolol: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis","volume":"167","author":"Sato","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.iccn.2025.104265_b0345","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1097\/CCM.0000000000006604","article-title":"Impact of short-acting beta-blockers on the outcomes of patients with septic shock: a systematic review and meta-analysis","volume":"53","author":"McChesney","year":"2025","journal-title":"Crit Care Med"}],"container-title":["Intensive and Critical Care Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0964339725003271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0964339725003271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:41:39Z","timestamp":1765197699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0964339725003271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":69,"alternative-id":["S0964339725003271"],"URL":"https:\/\/doi.org\/10.1016\/j.iccn.2025.104265","relation":{},"ISSN":["0964-3397"],"issn-type":[{"value":"0964-3397","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ultrashort-acting \u03b2-blocker on the mortality of patients with sepsis or septic shock: A systematic review and trial sequential meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Intensive and Critical Care Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccn.2025.104265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104265"}}